Lyra, a Burlingame, CA-based behavioral health technology company, secured $3.1m in strategic funding.
Castlight Health (NYSE: CSLT) made the investment and Castlight’s CEO, Giovanni Colella, MD, joined Lyra Health’s board of directors.
The company intends to use the funds to accelerate development.
Led by David Ebersman, co-founder and CEO, Lyra Health is developing a platform to identify people at risk of behavioral and mental health conditions. Through a combination of technology and a human touch, Lyra will identify, engage, and coordinate care for people with behavioral health issues; guide and match patients with the right providers and treatments; and assess treatment outcomes to better understand what works so that patients get the best care.
The two companies also announced a strategic alliance to develop and bring to market an integrated behavioral health solution to enterprise customers to help employees suffering from behavioral health conditions such as depression, anxiety, and substance abuse.